RKH-14290-17252
2 vaccinations
2 coded responses
12 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 276 / NC
- Registered
- 2021-04-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-02
Dose 1 — Pfizer-BioNTech
-
2021-04-04
Registered in v-safe
-
2021-04-04
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Headache · Be unable to workAdult check-in
- 2021-04-04
- 2021-04-06
- 2021-04-07
- 2021-04-11
- 2021-04-16
-
2021-04-23
Dose 2 — Pfizer-BioNTech
- 2021-04-23
-
2021-04-24
Survey response — days 1–6 daily, dose 2MedDRA: Blood glucose increased — Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessFree text: High blood sugarMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-25
Survey response — days 1–6 daily, dose 2MedDRA: Blood glucose increased — Feeling: GoodFree text: High blood sugarMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-26
- 2021-04-28
- 2021-05-07
- 2021-05-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-02 | Pfizer-BioNTech | |
| 2 | 2021-04-23 | Pfizer-BioNTech |
Call center
1 call center case
1 priority 2/3 (triaged and no follow up)
Free text
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): High blood sugar
Systemic reaction (other): High blood sugar
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Blood glucose increased | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release